journal article·2021-12-15

Poly(allylguanidine)-Coated Surfaces Regulate TGF-β in Glioblastoma Cells to Induce Apoptosis via NF-κB Pathway Activation

You-Ren Ji, Ching-Chia Cheng, An-Li Lee, Jonathan Chang-Cheng Shieh, Hsin-Ju Wu, Abel Po-Hao Huang, Yi-Hua Hsu, Tai-Horng Young

ACS Applied Materials & Interfaces· Volume 13· Issue 49
Publisher page

Abstract

Polycationic biomaterials are currently widely applied in neuronal cell cultures to promote cell adhesion and viability. However, polycations generally have cytotoxic properties that limit their application in the field of biomaterials. In this study, we examined the use of a novel polycation poly(allylguanidine) (PAG), which contains a guanidine group in the side chain and a structure similar to poly(allylamine hydrochloride) (PAH), an example of another commonly used polycation. Our findings showed that exposure to PAG induced apoptosis in glioblastoma (GBM) cells, while exposure to PAH induced necrosis. Compared to control groups, the PAG coating significantly limited the proliferation of GBM8901 in vitro and in vivo. Furthermore, GBM8901 cells exposed to the PAG coating exhibited increased levels of phospho-p65 and phosphor-IκB, implying that GBM8901 cells underwent apoptotic cell death via the NF-κB pathway by the regulation of TGF-β. This result was further confirmed to be consistent with the experimental results from western blot protein analysis and apoptosis/necrosis assays. These findings indicate that the polycation PAG has the potential to not only suppress the proliferation of GBM8901 cancer cells but also improve the neural viability and promote the differentiation of neural stem/precursor cells into mature neurons. In conclusion, biomaterials such as PAG act as extremely potent options for applications in the treatment of pathological conditions such as brain cancer.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · NF-κB Signaling Pathways · Wound Healing and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering, National Taiwan University, Taipei 100, Taiwan

Division of Plastic Surgery, Department of Surgery, MacKay Memorial Hospital, Taipei 104, Taiwan

Department of Medicine, MacKay Medical College, New Taipei City 252, Taiwan

Department of Surgery, National Taiwan University Hospital and College of Medicine, Taipei 100, Taiwan

Department of Biomedical Engineering, National Taiwan University Hospital, Taipei 100, Taiwan

Funding

Ministry of Science and Technology, Taiwan

References (33)

Show source-provided references
1. 10.1016/j.pharmthera.2015.05.00510.1016/j.pharmthera.2015.05.005 ↗
2. 10.1038/s41598-020-66608-310.1038/s41598-020-66608-3 ↗
3. 10.1093/neuonc/nos27310.1093/neuonc/nos273 ↗
4. 10.3322/caac.2161310.3322/caac.21613 ↗
5. 10.2147/cmar.s17332310.2147/cmar.s173323 ↗
6. 10.1586/erm.12.3010.1586/erm.12.30 ↗
7. 10.1101/cshperspect.a02061010.1101/cshperspect.a020610 ↗
8. 10.1038/s41593-018-0333-810.1038/s41593-018-0333-8 ↗
9. 10.1016/j.isci.2020.10142010.1016/j.isci.2020.101420 ↗
10. 10.1016/j.canlet.2019.09.00410.1016/j.canlet.2019.09.004 ↗
11. 10.1517/17425247.2010.48598310.1517/17425247.2010.485983 ↗
12. 10.1021/bm201142x10.1021/bm201142x ↗
13. 10.1016/j.ijpharm.2017.02.04810.1016/j.ijpharm.2017.02.048 ↗
14. 10.1016/j.heliyon.2021.e0651710.1016/j.heliyon.2021.e06517 ↗
15. 10.1016/j.biomaterials.2015.04.05210.1016/j.biomaterials.2015.04.052 ↗
16. 10.1021/acsami.9b1714310.1021/acsami.9b17143 ↗
17. 10.1002/0471142735.im1438s11210.1002/0471142735.im1438s112 ↗
18. 10.1021/jp108335710.1021/jp1083357 ↗
19. 10.1039/d0py01153c10.1039/d0py01153c ↗
20. 10.1021/jp405418y10.1021/jp405418y ↗
21. 10.1021/acsami.9b1743110.1021/acsami.9b17431 ↗
22. 10.1016/0014-4827(90)90124-s10.1016/0014-4827(90)90124-s ↗
23. 10.1186/s12867-015-0046-410.1186/s12867-015-0046-4 ↗
24. 10.1371/journal.pone.012273410.1371/journal.pone.0122734 ↗
25. 10.1126/scisignal.200441610.1126/scisignal.2004416 ↗
26. 10.1038/onc.2012.17110.1038/onc.2012.171 ↗
27. 10.1038/labinvest.2014.10010.1038/labinvest.2014.100 ↗
28. 10.1002/ijc.2985210.1002/ijc.29852 ↗
29. 10.1016/j.canlet.2016.10.00610.1016/j.canlet.2016.10.006 ↗
30. 10.1038/cr.2008.32810.1038/cr.2008.328 ↗
31. 10.1073/pnas.070011810410.1073/pnas.0700118104 ↗
32. 10.1038/bjc.1994.28010.1038/bjc.1994.280 ↗
33. 10.1016/j.ccr.2006.11.02310.1016/j.ccr.2006.11.023 ↗